Literature DB >> 1913648

Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth.

R D Beauchamp1, R J Coffey, R M Lyons, E A Perkett, C M Townsend, H L Moses.   

Abstract

A serotonin-secreting human pancreatic carcinoid cell line (BON) is demonstrated to express transcripts for all three mammalian types of transforming growth factor beta (TGF beta 1, 2, and 3). Similarly, freshly excised carcinoid tumors from six patients were also found to express mRNA for all three of the type-beta TGFs. Medium conditioned by BON cells had detectable TGF beta activity, although most of the activity was latent as determined by radioreceptor assay with and without prior acid treatment. However, nonactivated BON-conditioned medium stimulated DNA synthesis, soft agar growth, and an increase in TGF beta 1 and fibronectin mRNA expression in AKR-2B fibroblasts. In addition, BON-conditioned medium had a potent endothelial cell growth-stimulatory activity. Since the TGF beta s inhibit growth of endothelial cells, the presence of other growth factors was suspected. TGF alpha, c-sis, and basic fibroblast growth factor transcripts were also found to be expressed by the BON carcinoid cells. These data indicate that multiple peptide growth factors may have a paracrine role in the desmoplastic reaction accompanying carcinoid tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913648

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2).

Authors:  M Höltje; B von Jagow; I Pahner; M Lautenschlager; H Hörtnagl; B Nürnberg; R Jahn; G Ahnert-Hilger
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis.

Authors:  Scott R Silva; Kanika A Bowen; Piotr G Rychahou; Lindsey N Jackson; Heidi L Weiss; Eun Y Lee; Courtney M Townsend; B Mark Evers
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

3.  Site-specific epithelial-mesenchymal interactions in digestive neuroendocrine tumors. An experimental in vivo and in vitro study.

Authors:  J Dumortier; C Ratineau; J Y Scoazec; C Pourreyron; W Anderson; M F Jacquier; M Blanc; C Bernard; C Bellaton; L Remy; J A Chayvialle; C Roche
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

4.  Immunohistochemical localization of acidic fibroblast growth factor in normal human enterochromaffin cells and related gastrointestinal tumours.

Authors:  S La Rosa; A M Chiaravalli; C Capella; S Uccella; F Sessa
Journal:  Virchows Arch       Date:  1997-02       Impact factor: 4.064

5.  Management of Locally Advanced and Unresectable Small Bowel Neuroendocrine Tumours.

Authors:  Jonathan Koea
Journal:  World J Surg       Date:  2020-08-28       Impact factor: 3.352

6.  The role of fibronectin in tumor implantation at surgical sites.

Authors:  M S Murthy; E F Scanlon; R H Silverman; C R Goodheart; R A Goldschmidt; M L Jelachich
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

7.  Requirement of an intermediate gene expression for biphasic ERK1/2 activation in thrombin-stimulated vascular smooth muscle cells.

Authors:  Alejandra Pérez Sastre; Solveig Grossmann; H Peter Reusch; Michael Schaefer
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

8.  Biology and treatment of metastatic gastrointestinal neuroendocrine tumors.

Authors:  Jonathan R Strosberg; Aejaz Nasir; Pamela Hodul; Larry Kvols
Journal:  Gastrointest Cancer Res       Date:  2008-05

9.  Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells.

Authors:  M E Harper; E Glynne-Jones; L Goddard; V J Thurston; K Griffiths
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

10.  PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors.

Authors:  Elisabetta Cavalcanti; Antonia Ignazzi; Francesco De Michele; Maria Lucia Caruso
Journal:  Cancer Biol Ther       Date:  2018-10-22       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.